FDA Approves Johnson & Johnson's Ketamine-Derived Nasal Spray for Depression
Jan 23, 2025
468
FDA approves Spravato, a ketamine-derived nasal spray by Johnson & Johnson, for treatment-resistant depression, offering rapid relief and new hope for patients.